Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Recruiting · NCT06440746 · Registry updated 2024-11-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases | interstitial lung disease, lung disorder, respiratory system disorder | Recruiting | Phase 2 / Phase 3 | 2024-11-19 | NCT06440746 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Data Management 365 | 4 |
| Exacte Labs LLC | 5 |
| Keystat, LLC | 2 |
| R-Pharm | 6 |
| R-Pharm International, LLC | 8 |
33 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.